Ocular Therapeutix Inc (OCUL)

SG&A Expense Growth

7.80%

Quarterly · Period ending:

OCUL logo

OCUL SG&A Expense Growth

Latest reported7.80%
OCUL Quarterly SG&A Growth (QoQ) (0.00% → 7.80%)
High-resolution chart · PNG

OCUL sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
7.796%
19.4898%
5.1735%
3.6866%
-7.9387%
19.8789%
11.5354%
-23.1148%
21.9277%
40.8801%
-3.5142%
-7.5369%
-3.0257%
5.7253%
0.8762%
4.4068%
7.864%
-0.3059%
-5.5628%
3.8778%
7.8916%
17.6501%
7.267%
10.4709%
-8.1911%
-3.0489%
-1.8481%
5.2837%
41.1028%
17.4447%
34.4215%
3.7636%
-3.1706%
5.9051%
-30.6106%
-29.2535%
13.4688%
68.2887%
41.1284%
-12.2732%
17.6548%
1.6609%
14.8969%
-0.6726%
18.343%
-3.8274%
19.501%
38.937%
-8.1698%
226.6898%
-11.3671%
11.2821%
2.0942%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.